With new transcatheter options for the repair or replacement of tricuspid valves, the role and timing of repair — whether surgical or minimally invasive — is entering a time of transition.
CoreMedic announced that it picked up new funding in a Series B extension to support its transcatheter mitral valve repair ...
Company has N G Jain & Co. as its auditors. As on 31-03-2024, the company has a total of 2.38 Crore shares outstanding.Avon Lifesciences Share Price Today is Rs. 2.86. On previous day, the Avon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback